---
title: 'A multi-centric, single-blinded, randomized, parallel-group study to evaluate
  the effectiveness of nasoalveolar moulding treatment in non-syndromic patients with
  complete unilateral cleft lip, alveolus and palate (NAMUC study): a study protocol
  for a randomized controlled trial'
date: '2024-07-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38965585/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240705181629&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Cleft lip and palate (CLP) are among the most common congenital
  anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding
  (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce
  the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has
  been a controversial treatment option with 51% of the cleft teams in Europe, 37%
  of teams in the USA and 25 of cleft teams in India adopting this methodology. ...'
disable_comments: true
---
BACKGROUND: Cleft lip and palate (CLP) are among the most common congenital anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has been a controversial treatment option with 51% of the cleft teams in Europe, 37% of teams in the USA and 25 of cleft teams in India adopting this methodology. ...